← ANALYST RATINGS · TIPRANKS
Kenvue, Inc. (KVUE): analyst forecast and price target
Analyst consensus
Moderate Buy1 Buy2 Hold0 Sell
Ratings of 3 analysts in the last 3 months · top analysts only12-month forecast
Based on 3 price targets given in the last 3 months, the average target is $19.00, the highest $19.00, the lowest $19.00. The average is +0.5% from the last price of $18.91.
Analyst ratings 10
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Peter Grom★★★★★★★★★★#10681 · hits 52% · avg −1.8% | UBS | $19.00 | Hold | +0.5% | Reiterated | 15.10.26on TipRanks Oct 16 05:20 | +3.4%next day +2.4% | ↗ |
| Filippo Falorni★★★★★★★★★★#5471 · hits 56% · avg +1.6% | Citi | $19.00 | Hold | +0.5% | Reiterated | 14.10.26on TipRanks 06:40 | +2.5%next day +3.4% | ↗ |
| AI xAi Household and Personal ProductsxAI Grok-3 | TipRanks - xAI | $22.00 → $19.50−11.4% | Hold | +3.1% | Downgrade | 13.10.26on TipRanks 11:05 | — | |
| AI DeepSeek Household and Personal ProductsDeepSeek R1-0528 | TipRanks - DeepSeek | $22.50 → $19.50−13.3% | Buy | +3.1% | Reiterated | 13.10.26on TipRanks 11:05 | — | |
| AI OpenAI Household and Personal ProductsOpenAI 4o | TipRanks - OpenAI | $21.00 → $18.50−11.9% | Hold | −2.2% | Reiterated | 13.10.26on TipRanks 11:05 | — | |
| AI Anthropic Household and Personal ProductsAnthropic Opus-4.1 | TipRanks - Anthropic | $20.00 → $18.50−7.5% | Hold | −2.2% | Reiterated | 13.10.26on TipRanks 11:05 | — | |
| AI Google Household and Personal ProductsGemini 2.5Pro | TipRanks - Google | $22.00 → $20.00−9.1% | Buy | +5.8% | Reiterated | 13.10.26on TipRanks 11:05 | — | |
| AI PerPlexity Household and Personal ProductsPerPlexity SonarPro | TipRanks - PerPlexity | $21.00 → $19.00−9.5% | Hold | +0.5% | Reiterated | 13.10.26on TipRanks 11:05 | — | |
| Susan Anderson★★★★★★★★★★#576 · hits 45% · avg +16.7% | Canaccord Genuity | — | Buy | — | Reiterated | 16.09.26on TipRanks Sep 17 08:35 | −0.1%next day −0.9% · 5 days −1.8% | ↗ |
| Taylor Conrad★★★★★★★★★★#2766 · hits 62% · avg +8.8% | Argus Research | — | Hold | — | Reiterated | 14.09.26on TipRanks Sep 15 09:25 | +1.2%next day +0.5% · 5 days −2.1% | ↗ |
| Nik Modi★★★★★★★★★★#5747 · hits 52% · avg +0.9% | RBC Capital | $21.00 → $20.00−4.8% | Hold | +5.8% | Reiterated | 07.08.26on TipRanks Aug 10 21:45 | −0.3%next day −1.0% · 5 days +0.6% | ↗ |
| Jon Andersen★★★★★★★★★★#11312 · hits 50% · avg −3.7% | William Blair | — | Hold | — | Reiterated | 06.08.26on TipRanks 17:59 | −0.3%next day −1.0% · 5 days +0.6% | ↗ |
| Lauren Lieberman★★★★★★★★★★#2069 · hits 57% · avg +4.4% | Barclays | $19.00 | Hold | +0.5% | Reiterated | 06.08.26on TipRanks 04:16 | −2.3%next day −0.3% · 5 days 0.0% | ↗ |
| Javier Escalante★★★★★★★★★★#8974 · hits 47% · avg −0.6% | Evercore ISI | $18.00 | Hold | −4.8% | Reiterated | 18.02.26on TipRanks 09:45 | +2.1%next day −0.9% · 5 days −1.6% | ↗ |
| Keith Devas★★★★★★★★★★#11126 · hits 14% · avg −11.8% | Jefferies | $18.00 | Hold | −4.8% | Downgrade | 30.01.26on TipRanks Jan 29 21:11 | +1.5%next day −0.6% · 5 days +4.4% | ↗ |
| Stephen Powers★★★★★★★★★★#2604 · hits 62% · avg +3.7% | Deutsche Bank | $20.00 → $18.00−10.0% | Hold | −4.8% | Reiterated | 24.10.25on TipRanks 07:45 | −1.4%next day −0.6% · 5 days −4.9% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Kenvue, Inc.
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $19.25 at a price of $17.66 (+9.0%); now: $19.25 at $18.91 (+1.8%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 6 | 5 | 4 | 4 | 5 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 11.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.29 (from $0.26 to $0.32). Last quarter: $0.31.
Sales
Next quarter’s sales estimate — $3.9B (from $3.8B to $3.9B). Last quarter: $4.0B.
Best top-analyst consensus in the sector · Consumerdefensive
About Kenvue, Inc.
- CEO: Kirk L. Perry
- Employees: 21,890
- 1 Kenvue Way, Summit, NJ, 07901, US
- www.kenvue.com
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
Data from the stock’s TipRanks forecast page, read 92 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗